Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.07. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
21.06. | biote Corp. - 8-K, Current Report | - | SEC Filings | ||
20.06. | Biote announces $60 million agreement to repurchase 8.3 million shares | 1 | Seeking Alpha | ||
24.05. | biote Corp. - 8-K, Current Report | 2 | SEC Filings | ||
20.05. | ASTS, Lucy Scientific and BTMD among pre-market losers | 1 | Seeking Alpha | ||
10.05. | biote Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
07.05. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
07.05. | Biote Reports First Quarter 2024 Financial Results | 44 | Business Wire | IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness,... ► Artikel lesen | |
29.04. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
04.04. | biote Corp. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
15.03. | biote Corp. - 10-K, Annual Report | 1 | SEC Filings | ||
13.03. | Jefferies raises Biote stock target to $8.24, maintains buy rating | 1 | Investing.com | ||
12.03. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
12.03. | BIOTE GAAP EPS of $0.18 beats by $0.11, revenue of $45.7M in-line | 1 | Seeking Alpha | ||
12.03. | Biote: Q4 Earnings Insights | 1 | Benzinga.com | ||
12.03. | Biote Reports Fourth Quarter and Full Year 2023 Financial Results | 132 | Business Wire | IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness,... ► Artikel lesen | |
11.03. | Preview: Biote's Earnings | 1 | Benzinga.com | ||
20.02. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
20.02. | Biote shares rise on bullish B.Riley initiation | 1 | Investing.com | ||
01.02. | Jefferies sets $6.55 target on Biote with new buy rating | 1 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
TALKSPACE | 2,035 | -2,16 % | Talkspace, Inc. (TALK): Hedge Funds Are Bullish On This NASDAQ Penny Stock Now |